from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3115/-

LFCtreatmentdescriptionclass of inhibitor

0.019

Amikacinug/mL Amikacintranslation

0.021

Cap5-10ug/mL Capreomycintranslation

0.128

Rox10-50 ug/mL Roxithromycintranslation

-0.260

SM2-5 ug/mL Streptomycintranslation

0.028

Tet5-10 ug/mL Tetracyclinetranslation

0.353

Rif0.2-5ug/mL Rifampicintranscription

-0.417

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.784

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.026

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.376

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.767

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.619

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.437

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

3.972

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.861

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.692

Nigericin50 uM Nigericinrespiration

-0.254

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

2.033

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.796

menadione6-10 ug/mL Menadionerespiration

-0.044

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.120

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.569

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

3.683

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.208

NRP_1Non-replicating persistence stage 1dosRassociated

0.242

Amp0.2mg/mL AmpicillincellWall

-0.272

Cephalexin20-100 ug/mL CephalexincellWall

-0.336

Cerulenin0.32-5 ug/mL CerulenincellWall

0.332

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.336

EMB10-20 ug/mL EthambutolcellWall

-0.273

Eta12-40 ug/mL EthionamidecellWall

-0.292

INH0.2-0.4 ug/mL IsoniazidcellWall

0.003

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.452

BZA0.12 mg/mL BenzamidearomaticAmides

-0.378

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.436

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.633

H2O24 mM hydrogen peroxideDNAdamaging

0.493

Levo10 ug/mL LevofloxacinDNAdamaging

-0.787

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.788

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.652

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.328

Antimycin12.5-50 ug/mL Antimycin A?

2.136

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.712

PA_110-50 ug/mL Antitubercular compound PA-1?

0.032

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.228

PA8240.2-2 ug/mL PA-824?

0.989

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.152

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

2.672

Verapamil50 uM Verapamil?

2.996

mercaptoethanol2 mM 2-Mercaptoethanol?

4.849

methoxatin10-20 ug/mL Methoxatin?